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ABSTRACT
The results presented in this paper demonstrate that most of the honeybee gut
Bifidbacteria have potential antbacterial activities against different drug multi-
resistant human pathogens. Bacteria associated with the native Saudi Arabian
honeybee, A. m. jemenitica could be used to develop various pathogen
management strategies. The use of symbiotic gut bacteria could represent a
natural alternative to the use of synthetic antibiotics in the control of various
humandisease caused by pathogenic bacteria, which should therefore reduce
antibiotic resistance and the levels of antibiotic residues. Further research must
be conducted on these beneficial bacteria to isolate the active antagonistic
compound that kill these human pathogens.
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The honeybee (Apis mellifera) is a highly valued resource worldwide and is
of great relevance for humans and the entire ecosystem (vanEngelsdorp &
Meixner; 2010). The total annual global economic worth of pollination
amounts 202 billion USD, representing 10% of the value of the global
agricultural production. However, very unfortunately, this honeybee is
facing enormous threat worldwide including Saudi Arabia from a wide
range of infectious diseases, including American foulbrood (AFB),
European foulbrood (EFB), Chalkbrood disease, Nosema disease, and a
variety of viral pathogens (Al-Ghamdi, 1990). Hence, the declines of both
managed and wild pollinators are of increasing concern (vanEngelsdorp &
Meixner; 2010) because of food security issues.
Bifidobacteria are the principal commensal microflora of the human and
animal gastrointestinal tracts. They are widely used as human and animal
probiotics because of their potential benefits to the host. Three
Bifidobacterium species have been so far isolated from the insect digestive
tract: Bifidobacterium asteroides and Bifidobacterium coryneforme are the
two species found in the Apis mellifera intestine, and Bifidobacterium
indicum in the intestine of Apis cerana and Apis dorsata from the
Philippines and Malaysia (Scardovi & Trovatelli; 1969). Three distinct
bifidobacterial phylotypes were isolated from the digestive tract of the
Japanese honeybee, Apis cerana japonica (Wu et al. 2013).
The indigenous bee race of Saudi Arabia, A. m. jemenitica Ruttner has
been used in apiculture throughout the Arabian Peninsula since at least
2000 BC. It is the smallest race of A. mellifera, and well established in local
harsh environmental conditions, including high temperatures and low
rainfall and tolerates hunger for long periods of time (Alqarni et al. 2011).
Given the lack of information on the incidence of bifidobacteria in this
honeybee species, we characterized bifidobacteria isolated from the
intestinal tract of the Saudi Arabian honeybee and investigated the
potential antagonistic effect of these bacteria on some Drug Multi-
Resistant human pathogens.
Bifidobacteria were isolated from the intestinal tract of the indigenous
honeybee of Saudi Arabia, Apis mellifera jemenitica, and investigated for
potential application as a probiotic agent against some drug multi-resistant
human pathogen, based on the findings of in vitro inhibition assays. A total
of 05 bifidobacteria strains (designated as KsuBF01-KsuBF05) were isolated
using a culture-dependent method and their 16S rRNA gene sequences were
analysed. The KsuBF isolates belonged to three distinct bifidobacterial
phylotypes that were similar to those found in the Japanese honeybee, Apis
cerana japonica. Although the Saudi Arabian and Japanese honeybees are
distinct species with different traits and habits, the observation that they
share highly similar bifidobacterial phylotypes suggests that bifidobacteria
are conserved among honeybee species. Despite having extremely high 16S
rRNA gene sequence similarities, the KsuBF isolates had markedly different
carbohydrate fermentation profiles. In addition, in vitro growth inhibition
assays revealed that the cell-free supernatants of all KsuBF isolates
exhibited antagonistic effects on Drug multi-resistant E. coli, P. aureginosa,
B. subtilis and S. aureus growth. These results indicate that the
bifidobacteria isolated from the gut of indigenous Saudi Arabian honeybee
could potentially be employed to produce some probiotics against some
human pathogens.
METHODOLOGY
Table: In vitro antagonistic effect of gut Bifidobacterial isolates against 
different human drug multi-resistant isolates
CONCLUSIONSINTRODUCTION
In March 2013, 10 adult workers of A. m. jemenitica were collected at the entrance of a
hive in the Al-Baha area of Saudi Arabia and their digestive tracts were dissected
aseptically. Wilkins-Chalgren medium (Oxoid, UK) was used as selective medium for
isolating bifidobacteria (Ferraris et al., 2010). Colonies grown on the plates were
selected according to small size and white color. A total of nine bifidobacterial colonies
were obtained and repeatedly grown on Wilkins-Chalgren agar plates.
The pure isolated colonies were used as templates for polymerase chain reaction (PCR)
amplification of 16S rRNA genes. The 16S rRNA genes of bifidobacteria were amplified
using primers Im26 (50-GAT TCT GGC TCA GGA TGA ACG-30) and Im3 (50-CGG GTG CTI
CCC ACT TTC ATG-30) (Kaufmann et al., 1997). Biochemical typing of each of the nine
bifidobacterial colonies was performed using an API 50CH biochemical kit with the
supplied medium (BioMerieux).
In vitro growth inhibition assay was performed and nine bifidobacteria strains were
cultured anaerobically on Wilkins-Chalgren liquid medium at 35 C for 48 h. The cell-free
supernatant (CFS) was recovered by centrifugation at 4000g for 4 min at 10 C and
filtered (pore size: 0.22 µm. Drug multi-resistant human pathogens were cultured on
nutrient agar plates at 35 C. Antagonistic activity was performed using cell diffusion
assay.
Scanning electron microscopy (SEM) (Leo 435, Cambridge, USA) was performed to
examine the morphological characteristics of the isolated bifidobacteria.
RESULTS
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FIG. 1: Scanning electron micrographs of ksuBF isolates (ksuBF-1 - ksuBF-5)
Bifidobacerium
isolates/Human 
Isolates
Mean (±SD) diameter of inhibition zone
against different Human Isolates (in mm)
E. coli P. aureginosa S. aureus
ksuBF-1 20.25 ± 1.2 21.50 ± 1.4 21.25 ± 1.1
ksuBF-2 12.25 ± 0.7 19.25 ± 1.0 12.00 ± 0.6
ksuBF-3 11.75 ± 0.5 12.50 ± 0.4 13.25 ± 0.4
ksuBF-4 10.75 ± 0.6 12.25 ± 0.4 14.50 ± 0.5
ksuBF-5 10.75 ± 0.7 10.75 ± 0.3 04.50 ± 0.4
